Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors: Dual activities and metabolic activation

Shinnosuke Hosoda; Aya Tanatani; Ken ichi Wakabayashi; Makoto Makishima; Keisuke Imai; Hiroyuki Miyachi; Kazuo Nagasawa; Yuichi Hashimoto

doi:10.1016/j.bmc.2006.04.039

Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors: Dual activities and metabolic activation

Shinnosuke Hosoda, Aya Tanatani, Ken ichi Wakabayashi, Makoto Makishima, Keisuke Imai, Hiroyuki Miyachi, Kazuo Nagasawa, Yuichi Hashimoto

Faculty of Pharmaceutical Sciences

Research output: Contribution to journal › Article

39 Citations (Scopus)

Abstract

Ligands possessing dual vitamin D₃ (VD₃)-agonistic and androgen-antagonistic activities with various activity spectra were prepared based on a substituted 3,3-diphenylpentane (DPP) skeleton. Among the compounds, (R,S)-DPP-1023 [(R,S)-7b] and (S,S)-DPP-0123 [(S,S)-7c] showed the most potent vitamin D₃-agonistic activity [with potency comparable to that of 1α,25-dihydroxyvitamin D₃ (1,25-VD₃)] and nuclear androgen receptor (AR)-binding activity (with higher affinity than that of hydroxyflutamide), respectively. Metabolic activation (reduction of the carbonyl group) of pivaloyl analogs [DPP-1113 (3a), DPP-1013 (3b), DPP-0113 (3c), and DPP-0013 (3d)] in HL-60 cells was found to be necessary for binding to nuclear vitamin D₃ receptor (VDR).

Original language	English
Pages (from-to)	5489-5502
Number of pages	14
Journal	Bioorganic and Medicinal Chemistry
Volume	14
Issue number	16
DOIs	https://doi.org/10.1016/j.bmc.2006.04.039
Publication status	Published - Aug 15 2006

Keywords

Agonist
Androgen
Antagonist
Diphenylpentane
Metabolism
Vitamin D

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmc.2006.04.039

Fingerprint Dive into the research topics of 'Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors: Dual activities and metabolic activation'. Together they form a unique fingerprint.

Cite this

Hosoda, S., Tanatani, A., Wakabayashi, K. I., Makishima, M., Imai, K., Miyachi, H., Nagasawa, K., & Hashimoto, Y. (2006). Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors: Dual activities and metabolic activation. Bioorganic and Medicinal Chemistry, 14(16), 5489-5502. https://doi.org/10.1016/j.bmc.2006.04.039

Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors : Dual activities and metabolic activation. / Hosoda, Shinnosuke; Tanatani, Aya; Wakabayashi, Ken ichi; Makishima, Makoto; Imai, Keisuke; Miyachi, Hiroyuki; Nagasawa, Kazuo; Hashimoto, Yuichi.

In: Bioorganic and Medicinal Chemistry, Vol. 14, No. 16, 15.08.2006, p. 5489-5502.

Research output: Contribution to journal › Article

@article{ec859aadd00d4587ac3bd1e4e3b08b39,

title = "Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors: Dual activities and metabolic activation",

abstract = "Ligands possessing dual vitamin D3 (VD3)-agonistic and androgen-antagonistic activities with various activity spectra were prepared based on a substituted 3,3-diphenylpentane (DPP) skeleton. Among the compounds, (R,S)-DPP-1023 [(R,S)-7b] and (S,S)-DPP-0123 [(S,S)-7c] showed the most potent vitamin D3-agonistic activity [with potency comparable to that of 1α,25-dihydroxyvitamin D3 (1,25-VD3)] and nuclear androgen receptor (AR)-binding activity (with higher affinity than that of hydroxyflutamide), respectively. Metabolic activation (reduction of the carbonyl group) of pivaloyl analogs [DPP-1113 (3a), DPP-1013 (3b), DPP-0113 (3c), and DPP-0013 (3d)] in HL-60 cells was found to be necessary for binding to nuclear vitamin D3 receptor (VDR).",

keywords = "Agonist, Androgen, Antagonist, Diphenylpentane, Metabolism, Vitamin D",

author = "Shinnosuke Hosoda and Aya Tanatani and Wakabayashi, {Ken ichi} and Makoto Makishima and Keisuke Imai and Hiroyuki Miyachi and Kazuo Nagasawa and Yuichi Hashimoto",

year = "2006",

month = aug,

day = "15",

doi = "10.1016/j.bmc.2006.04.039",

language = "English",

volume = "14",

pages = "5489--5502",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Limited",

number = "16",

}

TY - JOUR

T1 - Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors

T2 - Dual activities and metabolic activation

AU - Hosoda, Shinnosuke

AU - Tanatani, Aya

AU - Wakabayashi, Ken ichi

AU - Makishima, Makoto

AU - Imai, Keisuke

AU - Miyachi, Hiroyuki

AU - Nagasawa, Kazuo

AU - Hashimoto, Yuichi

PY - 2006/8/15

Y1 - 2006/8/15

N2 - Ligands possessing dual vitamin D3 (VD3)-agonistic and androgen-antagonistic activities with various activity spectra were prepared based on a substituted 3,3-diphenylpentane (DPP) skeleton. Among the compounds, (R,S)-DPP-1023 [(R,S)-7b] and (S,S)-DPP-0123 [(S,S)-7c] showed the most potent vitamin D3-agonistic activity [with potency comparable to that of 1α,25-dihydroxyvitamin D3 (1,25-VD3)] and nuclear androgen receptor (AR)-binding activity (with higher affinity than that of hydroxyflutamide), respectively. Metabolic activation (reduction of the carbonyl group) of pivaloyl analogs [DPP-1113 (3a), DPP-1013 (3b), DPP-0113 (3c), and DPP-0013 (3d)] in HL-60 cells was found to be necessary for binding to nuclear vitamin D3 receptor (VDR).

AB - Ligands possessing dual vitamin D3 (VD3)-agonistic and androgen-antagonistic activities with various activity spectra were prepared based on a substituted 3,3-diphenylpentane (DPP) skeleton. Among the compounds, (R,S)-DPP-1023 [(R,S)-7b] and (S,S)-DPP-0123 [(S,S)-7c] showed the most potent vitamin D3-agonistic activity [with potency comparable to that of 1α,25-dihydroxyvitamin D3 (1,25-VD3)] and nuclear androgen receptor (AR)-binding activity (with higher affinity than that of hydroxyflutamide), respectively. Metabolic activation (reduction of the carbonyl group) of pivaloyl analogs [DPP-1113 (3a), DPP-1013 (3b), DPP-0113 (3c), and DPP-0013 (3d)] in HL-60 cells was found to be necessary for binding to nuclear vitamin D3 receptor (VDR).

KW - Agonist

KW - Androgen

KW - Antagonist

KW - Diphenylpentane

KW - Metabolism

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=33745604630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745604630&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2006.04.039

DO - 10.1016/j.bmc.2006.04.039

M3 - Article

C2 - 16698269

AN - SCOPUS:33745604630

VL - 14

SP - 5489

EP - 5502

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 16

ER -